| Influence of EGFR mutation status and PD‐L1 expression in stage III unresectable non‐small cell lung cancer treated with chemoradiation and consolidation … U Nindra, A Shahnam, S Stevens, A Pal, A Nagrial, J Lee, PY Yip, T Adam, ... Asia‐Pacific Journal of Clinical Oncology 20 (1), 16-24, 2024 | 5 | 2024 |
| Elevated neutrophil‐to‐lymphocyte ratio (NLR) is associated with poorer progression‐free survival in unresectable stage III NSCLC treated with consolidation durvalumab U Nindra, A Shahnam, S Stevens, A Pal, A Nagrial, J Lee, PY Yip, T Adam, ... Thoracic Cancer 13 (21), 3058-3062, 2022 | 5 | 2022 |
| 965P Real-world toxicity of consolidation durvalumab following chemoradiotherapy (CRT) in elderly and comorbid patients (pts) with unresectable stage III NSCLC: A multi-centre … S Stevens, U Nindra, A Shahnam, V Bray, A Pal, PY Yip, T Adam, ... Annals of Oncology 33, S989, 2022 | 3 | 2022 |
| Effect of delayed consolidation durvalumab and timing of treatment on survival outcomes in patients (pts) with unresectable stage III non-small cell lung cancer (NSCLC) treated … SX Stevens, U Nindra, A Shahnam, VJ Bray, PY Yip, T Adam, JHJ Lee, ... Journal of Clinical Oncology 40 (16_suppl), e18809-e18809, 2022 | 1 | 2022 |
| Patient utilisation of cancer therapies in western New South Wales following introduction of remote video assisted chemotherapy (RVAC) S Stevens, F Honeyball ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 16, 178-178, 2020 | 1 | 2020 |
| Real world efficacy and toxicity of consolidation durvalumab following chemoradiotherapy in older Australian patients with unresectable stage III non-small cell lung cancer S Stevens, U Nindra, A Shahnam, J Wei, V Bray, A Pal, PY Yip, A Linton, ... Journal of Geriatric Oncology 15 (2), 101705, 2024 | | 2024 |
| Prognostic Nutritional Index (PNI) predicts progression free survival in patients with unresectable stage III non-small cell lung cancer treated with consolidation durvalumab U Nindra, A Shahnam, SX Stevens, A Pal, PY Yip, T Adam, J Lee, ... ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 18, 166-166, 2022 | | 2022 |
| Patterns of care post progression for NSCLC patients treated with definitive chemoradiation and durvalumab A Shahnam, U Nindra, SX Stevens, V Bray, PY Yip, T Adam, J Lee, ... ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 18, 140-141, 2022 | | 2022 |
| The prognostic influence of neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) in stage III non-small cell lung cancer (NSCLC) treated with … U Nindra, A Shahnam, SX Stevens, A Pal, PY Yip, T Adam, JHJ Lee, ... Journal of Clinical Oncology 40 (16_suppl), e18773-e18773, 2022 | | 2022 |
| Brave Journey Home. SX Stevens Journal of Clinical Oncology: Official Journal of the American Society of …, 2017 | | 2017 |
